Chargement en cours...
Clinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A(1)chieve study
AIM: To explore the clinical safety and effectiveness of insulin detemir (IDet) in a subgroup of Indian patients with type 2 diabetes (T2D) switched from either insulin glargine (IGlar) or neutral protamine Hagedorn (NPH) insulin in the 24-week, non-interventional A(1)chieve study. MATERIALS AND MET...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4171898/ https://ncbi.nlm.nih.gov/pubmed/25285292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.139239 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|